• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Comprehensive Overview of tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate (CAS No. 1260593-51-8)

tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate (CAS No. 1260593-51-8) is a specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. This chiral morpholine derivative has garnered significant attention due to its unique structural features and versatile applications. The compound's morpholine core and tert-butyl carboxylate group make it a valuable building block for drug discovery, particularly in the development of kinase inhibitors and other bioactive molecules.

In recent years, the demand for chiral intermediates like tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate has surged, driven by the pharmaceutical industry's focus on enantioselective synthesis. Researchers frequently search for "morpholine derivatives in drug design" or "CAS 1260593-51-8 applications," reflecting the compound's relevance in modern medicinal chemistry. Its aminoethyl side chain provides an excellent handle for further functionalization, enabling the creation of diverse molecular architectures.

The synthesis of tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate typically involves asymmetric methodologies to ensure high enantiomeric purity, a critical factor for pharmaceutical applications. Current trends in green chemistry have prompted investigations into more sustainable routes for producing such chiral building blocks, with many scientists exploring "catalytic asymmetric synthesis of morpholine derivatives." The compound's stability under various conditions makes it particularly attractive for multi-step synthetic sequences.

Analytical characterization of CAS 1260593-51-8 employs advanced techniques including chiral HPLC, NMR spectroscopy, and mass spectrometry. These methods ensure the compound meets the stringent purity requirements for pharmaceutical intermediates. The growing interest in "quality control of chiral compounds" underscores the importance of robust analytical protocols for molecules like tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate.

Beyond pharmaceutical applications, this compound has shown potential in materials science, particularly in the development of functionalized polymers. The morpholine ring's ability to coordinate with metal ions has led to exploration in catalytic systems, addressing popular search queries like "nitrogen-containing ligands in catalysis." The tert-butyl ester group offers convenient deprotection options, facilitating diverse downstream modifications.

Storage and handling of tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate require standard laboratory precautions. While not classified as hazardous under normal conditions, proper storage under inert atmosphere at low temperatures is recommended to maintain stability. This aligns with industry best practices for amine-containing compounds and responds to common concerns about "long-term storage of sensitive intermediates."

The commercial availability of CAS 1260593-51-8 from multiple specialty chemical suppliers has facilitated its adoption across research institutions. Current market analyses indicate growing demand for such pharmaceutical intermediates, particularly in regions with strong generic drug development sectors. This trend reflects broader industry movements toward "cost-effective chiral synthesis" strategies.

Future research directions for tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate may explore its potential in novel drug delivery systems or as a scaffold for bioactive compound libraries. The compound's structural features position it well for investigations into "targeted molecular therapeutics" and "multifunctional drug design," both areas receiving substantial research funding globally.

In conclusion, tert-Butyl (S)-2-(2-aminoethyl)morpholine-4-carboxylate represents an important tool in modern synthetic chemistry, bridging academic research and industrial applications. Its combination of chirality, functional group diversity, and synthetic versatility ensures continued relevance in addressing current challenges in medicinal chemistry and materials science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)